Rare Disease Medical Partner, Neurology, Gulf Astrazeneca Pharma India Ltd.

About AstraZeneca Rare Disease

AstraZeneca is redefining the future of rare disease medicines across the Gulf region. With over 7,000 known rare diseases and fewer than 1% having approved therapies, our mission is clear: to accelerate diagnosis, expand access, and transform patient care through science, collaboration, and compassion.

As we continue our bold expansion across the Gulf region, we are establishing a new level of field-based medical leadership: the Rare Disease Medical Partner a role that combines deep scientific expertise with strategic partnership, evidence generation, and ecosystem shaping.

Role Summary

The Rare Disease Medical Partner (RDMP) is a senior field-based scientific and strategic leader responsible for driving medical excellence and shaping the rare disease ecosystem in alignment with AstraZeneca s vision of pioneering innovation for patients with high unmet needs.

Building on the foundations of the Medical Science Liaison (MSL) role, the RDMP extends beyond scientific exchange to deliver integrated medical impact and transforming patient care spanning early diagnosis initiatives, real-world evidence generation, medical education leadership, strategic stakeholder engagement, and cross-functional decision support.

You will partner with healthcare professionals, academic centers, policy makers, patient groups, and payers, ensuring science translates into meaningful patient outcomes across the Upper Gulf region. You will report to the Medical Manager, Neurology, Gulf and act as a trusted medical leader within the cross-functional brand team.

What You ll Do

1. Serve as the strategic medical partner to the cross-functional brand and launch teams, co-shaping regional medical strategies and evidence plans.
2. Translate global medical strategies into actionable local implementation roadmaps across diagnosis, treatment, and patient pathways.
3. Identify and lead medical opportunities that support disease awareness, early identification, and optimized care pathways in collaboration with key centers and national stakeholders.

1. Build and sustain deep, scientifically credible partnerships with Key External Experts (KEEs), academic networks, and regional Centers of Excellence.
2. Partner with national societies, government bodies, and advocacy organizations to shape rare disease policy and education frameworks.
3. Lead or co-create multi-stakeholder programs (registries, referral networks, etc.) that drive measurable patient impact.

1. Drive real-world data (RWD) and investigator-initiated research opportunities aligned with medical strategy.
2. Lead local data-to-insight translation, synthesizing field intelligence, disease trends, and competitor developments to inform strategic decision-making.
3. Ensure medical input into value dossiers, health-economics projects, and access narratives where scientifically appropriate.

1. Lead the design and execution of disease-state and scientific education programs, ensuring evidence-based, non-promotional delivery.
2. Support thought-leader development through train-the-trainer, speaker development, and expert-led roundtables.

1. Act as medical launch lead in assigned indications, coordinating readiness, training, and data-driven engagement across the field team.
2. Co-create and implement diagnostic and care-pathway initiatives with hospitals and diagnostic labs to reduce time to diagnosis.
3. Partner with cross-functional teams (Marketing, Market Access, Patient Engagement, and Corporate Affairs) to ensure medical integrity in all initiatives.

1. Provide strategic medical input in cross-functional planning and governance forums.
2. Lead internal capability-building sessions, driving a culture of evidence, insight, and ethics.
3. Act as medical owner for key regional projects, dashboards, and medical KPIs.